
Cochlear Ltd
ASX:COH

Cochlear Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
250.73
345.01
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Cochlear Ltd hold over its rivals?
What risks and challenges
does Cochlear Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Cochlear Ltd.
Provide an overview of the primary business activities
of Cochlear Ltd.
What unique competitive advantages
does Cochlear Ltd hold over its rivals?
What risks and challenges
does Cochlear Ltd face in the near future?
Has there been any significant insider trading activity
in Cochlear Ltd recently?
Summarize the latest earnings call
of Cochlear Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Cochlear Ltd.
Provide P/S
for Cochlear Ltd.
Provide P/E
for Cochlear Ltd.
Provide P/OCF
for Cochlear Ltd.
Provide P/FCFE
for Cochlear Ltd.
Provide P/B
for Cochlear Ltd.
Provide EV/S
for Cochlear Ltd.
Provide EV/GP
for Cochlear Ltd.
Provide EV/EBITDA
for Cochlear Ltd.
Provide EV/EBIT
for Cochlear Ltd.
Provide EV/OCF
for Cochlear Ltd.
Provide EV/FCFF
for Cochlear Ltd.
Provide EV/IC
for Cochlear Ltd.
Show me price targets
for Cochlear Ltd made by professional analysts.
What are the Revenue projections
for Cochlear Ltd?
How accurate were the past Revenue estimates
for Cochlear Ltd?
What are the Net Income projections
for Cochlear Ltd?
How accurate were the past Net Income estimates
for Cochlear Ltd?
What are the EPS projections
for Cochlear Ltd?
How accurate were the past EPS estimates
for Cochlear Ltd?
What are the EBIT projections
for Cochlear Ltd?
How accurate were the past EBIT estimates
for Cochlear Ltd?
Compare the revenue forecasts
for Cochlear Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Cochlear Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Cochlear Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Cochlear Ltd compared to its peers.
Compare the P/E ratios
of Cochlear Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Cochlear Ltd with its peers.
Analyze the financial leverage
of Cochlear Ltd compared to its main competitors.
Show all profitability ratios
for Cochlear Ltd.
Provide ROE
for Cochlear Ltd.
Provide ROA
for Cochlear Ltd.
Provide ROIC
for Cochlear Ltd.
Provide ROCE
for Cochlear Ltd.
Provide Gross Margin
for Cochlear Ltd.
Provide Operating Margin
for Cochlear Ltd.
Provide Net Margin
for Cochlear Ltd.
Provide FCF Margin
for Cochlear Ltd.
Show all solvency ratios
for Cochlear Ltd.
Provide D/E Ratio
for Cochlear Ltd.
Provide D/A Ratio
for Cochlear Ltd.
Provide Interest Coverage Ratio
for Cochlear Ltd.
Provide Altman Z-Score Ratio
for Cochlear Ltd.
Provide Quick Ratio
for Cochlear Ltd.
Provide Current Ratio
for Cochlear Ltd.
Provide Cash Ratio
for Cochlear Ltd.
What is the historical Revenue growth
over the last 5 years for Cochlear Ltd?
What is the historical Net Income growth
over the last 5 years for Cochlear Ltd?
What is the current Free Cash Flow
of Cochlear Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Cochlear Ltd.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
AU |
![]() |
Cochlear Ltd
ASX:COH
|
16.6B AUD | 44.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
214.6B USD | 16 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
163B USD | 70.2 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
133.6B USD | 72.1 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
128.7B USD | 43 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
105.1B USD | 24.7 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
58.2B USD | 33.3 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
49.3B EUR | 24.8 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
39.5B USD | 9.5 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
259.5B CNY | 21 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
30B USD | 24.1 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
AU |
![]() |
Cochlear Ltd
ASX:COH
|
Average P/E:
34.8
44.3
|
14%
|
3.2 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
16
|
-6%
|
N/A |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
70.2
|
20%
|
3.5 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
72.1
|
44%
|
1.6 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
43
|
28%
|
1.5 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
24.7
|
30%
|
0.8 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
33.3
|
42%
|
0.8 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
24.8
|
23%
|
1.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
9.5
|
-24%
|
N/A |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21
|
15%
|
1.4 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
24.1
|
18%
|
1.3 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.